Follow the 艾迪药业 share price and the full management transaction log of the company, a listed issuer based in China. Shares are listed on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 艾迪药业 has logged 14 reports. Market capitalisation: €6.6bn. The latest transaction was reported on 31 July 2026 (Purchase). Among the most active insiders: 傅和亮. The full history is openly available.
14
Insider Decl.
n/a
Thresholds
€2m
13 ops.
Buy Volume
€121,577
1 ops.
Sell Volume
21Σ signal
Buys €2m€121,577 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 21,454 of 28,836 companies
35.0
score / 100
Value
34
Quality
37
FCF yld-0.5%
Earn yld-0.3%
EV/EBITDA·
ROE-0.3%
Gross mgn67%
Net mgn-2.7%
Debt/EBITDA5.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
艾迪药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative pharmaceutical products.